Clinical impact of radiation-induced myocardial damage detected by cardiac magnetic resonance imaging and dose-volume histogram parameters of the left ventricle as prognostic factors of cardiac events after chemoradiotherapy for esophageal cancer

被引:3
|
作者
Umezawa, Rei [1 ]
Ota, Hideki [2 ]
Takagi, Hidenobu [2 ]
Kadoya, Noriyuki [1 ]
Nakajima, Yujiro [1 ,3 ]
Takahashi, Noriyoshi [1 ]
Yamamoto, Takaya [1 ]
Takase, Kei [2 ]
Jingu, Keiichi [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Radiat Oncol, 1-1 Seiryou Machi,Aobaku, Sendai 9808574, Japan
[2] Tohoku Univ, Grad Sch Med, Dept Diagnost Radiol, 1-1, Seiryou Machi,Aobaku, Sendai 9808574, Japan
[3] Komazawa Univ, Dept Radiol Sci, 1-23-1 Setagayaku, Tokyo 1548525, Japan
基金
日本学术振兴会;
关键词
esophageal cancer; radiotherapy; magnetic resonance imaging; radiation-induced myocardial damage; cardiac events; INDUCED HEART-DISEASE; RADIOTHERAPY; THERAPY; SURGERY; RISK; ECHOCARDIOGRAPHY; TOXICITY; FUTURE; TRIALS;
D O I
10.1093/jrr/rrad040
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
This prospective study aimed to evaluate whether radiation (RT)-induced myocardial damage by cardiac magnetic resonance (CMR) imaging could be a predictor of cardiac events after chemoradiotherapy (CRT) for esophageal cancer and determine the dose-volume histogram (DVH) parameters of the left ventricle (LV) in predicting cardiac events. CMR imaging was performed before and 6 months after CRT in patients receiving definitive CRT. RT-induced myocardial damage was defined as abnormal CMR findings indicating myocardial fibrosis corresponding to an isodose line of >= 30 Gy. The cutoff values of the LV DVH parameters were calculated using the receiver operating characteristic curve based on the presence of RT-induced myocardial damage. The prognostic factors related to cardiac events of Grade 3 or higher were examined. Twenty-three patients were enrolled in the study. RT-induced myocardial damage by late gadolinium enhancement and/or an increase of 100 ms or higher in native T1 post-CRT was detected in 10 of the 23 patients. LV V45 was the best predictive factor for RT-induced myocardial damage with a cutoff value of 2.1% and an area under the curve of 0.75. The median follow-up period was 82.1 months. The 5- and 7-year cumulative incidences of cardiac events of Grade 3 or higher were 14.7 and 22.4%, respectively. RT-induced myocardial damage and LV V45 were significant risk factors (P = 0.015 and P = 0.013, respectively). RT-induced myocardial damage is a significant predictor of cardiac events. LV V45 is associated with RT-induced myocardial damage and subsequent cardiac events.
引用
收藏
页码:702 / 710
页数:9
相关论文
共 8 条
  • [1] Analysis of dose-volume histogram parameters for radiation pneumonitis after definitive concurrent chemoradiotherapy for esophageal cancer
    Asakura, Hirofumi
    Hashimoto, Takayuki
    Zenda, Sadamoto
    Harada, Hideyuki
    Hirakawa, Koichi
    Mizumoto, Masashi
    Furutani, Kazuhisa
    Hironaka, Shuichi
    Fuji, Hiroshi
    Murayama, Shigeyuki
    Boku, Narikazu
    Nishimura, Tetsuo
    RADIOTHERAPY AND ONCOLOGY, 2010, 95 (02) : 240 - 244
  • [2] Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram
    Takeuchi, Yuki
    Murakami, Yuji
    Kameoka, Tsubasa
    Ochi, Masanori
    Imano, Nobuki
    Takahashi, Ippei
    Nishibuchi, Ikuno
    Kimura, Tomoki
    Kawahara, Daisuke
    Saito, Akito
    Nagata, Yasushi
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (02) : 298 - 306
  • [3] Dose-Dependent Radiation-Induced Myocardial Damage in Esophageal Cancer Treated With Chemoradiotherapy: A Prospective Cardiac Magnetic Resonance Imaging Study
    Umezawa, Rei
    Kadoya, Noriyuki
    Ota, Hideki
    Nakajima, Yujiro
    Saito, Masahide
    Takagi, Hidenobu
    Takanami, Kentaro
    Takahashi, Noriyoshi
    Ishikawa, Yojiro
    Yamamoto, Takaya
    Matsushita, Haruo
    Takeda, Ken
    Takase, Kei
    Jingu, Keiichi
    ADVANCES IN RADIATION ONCOLOGY, 2020, 5 (06) : 1170 - 1178
  • [4] DOSE VOLUME HISTOGRAM PARAMETERS AND CLINICAL FACTORS ASSOCIATED WITH PLEURAL EFFUSION AFTER CHEMORADIOTHERAPY IN ESOPHAGEAL CANCER PATIENTS
    Shirai, Katsuyuki
    Tamaki, Yoshio
    Kitamoto, Yoshizumi
    Murata, Kazutoshi
    Satoh, Yumi
    Higuchi, Keiko
    Nonaka, Tetsuo
    Ishikawa, Hitoshi
    Katoh, Hiroyuki
    Takahashi, Takeo
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (04): : 1002 - 1007
  • [5] Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes
    Tripp, P
    Malhotra, HK
    Javle, M
    Shaukat, A
    Russo, R
    De Boer, S
    Podgorsak, M
    Nava, H
    Yang, GY
    DISEASES OF THE ESOPHAGUS, 2005, 18 (06) : 400 - 405
  • [6] CLINICAL CURATIVE EFFECT OF CYTOKINES COMBINED WITH DOSE-VOLUME HISTOGRAM PARAMETERS AND FEATURES IN PREDICTING RADIATION-INDUCED LUNG INJURY FOR NON-SMALL CELL LUNG CANCER
    Chu, Li
    Yao, Xuepin
    Duan, Yingxin
    ACTA MEDICA MEDITERRANEA, 2022, 38 (04): : 2697 - 2704
  • [7] Cardiac Magnetic Resonance Imaging and Blood Biomarkers for Evaluation of Radiation-Induced Cardiotoxicity in Patients With Breast Cancer: Results of a Phase 2 Clinical Trial
    Speers, Corey
    Murthy, Venkatesh L.
    Walker, Eleanor M.
    Glide-Hurst, Carri K.
    Marsh, Robin
    Tang, Ming
    Morris, Emily L.
    Schipper, Matthew J.
    Weinberg, Richard L.
    Gits, Hunter C.
    Hayman, James
    Feng, Mary
    Balter, James
    Moran, Jean
    Jagsi, Reshma
    Pierce, Lori J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (02): : 417 - 425
  • [8] Incorporating dose-volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy
    Ursino, Stefano
    Giuliano, Alessia
    Di Martino, Fabio
    Cocuzza, Paola
    Molinari, Alessandro
    Stefanelli, Antonio
    Giusti, Patrizia
    Aringhieri, Giacomo
    Morganti, Riccardo
    Neri, Emanuele
    Traino, Claudio
    Paiar, Fabiola
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (03) : 209 - 218